Gray, M J <br/><br/>
Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver.  [electronic resource] 

 -  Oncogene  Dec 2008 
 - 7192-200 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/onc.2008.356  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--genetics<br/>Animals<br/>Apoptosis--physiology<br/>Autoradiography<br/>Blotting, Western<br/>Cell Line, Tumor<br/>Cell Proliferation<br/>Colorectal Neoplasms--genetics<br/>Flow Cytometry<br/>Humans<br/>Immunohistochemistry<br/>Immunoprecipitation<br/>Inhibitor of Differentiation Protein 2--genetics<br/>Liver Neoplasms--secondary<br/>Mice<br/>RNA, Small Interfering<br/>Signal Transduction--physiology<br/>Up-Regulation<br/>Xenograft Model Antitumor Assays